17DN.F · Arcadia Biosciences, Inc

-

Please sign in to comment on 17DN.F

1 Comment

Admin

4 years, 1 month ago

Arcadia Biosciences, Inc is currently in a long term downtrend where the price is trading 10.1% below its 200 day moving average.

From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 3.2.

Arcadia Biosciences, Inc's total revenue rose by 1613.9% to $7M since the same quarter in the previous year.

Its net income has increased by 242.5% to $9M since the same quarter in the previous year.

Finally, its free cash flow fell by 25.6% to $-7M since the same quarter in the previous year.

Based on the above factors, Arcadia Biosciences, Inc gets an overall score of 3/5.

Exchange	F
CurrencyCode	EUR
ISIN	US0390142042
Sector	Consumer Defensive
Industry	Packaged Foods

Target Price	6.23
Dividend Yield	0.0%
Beta	0.15
Market Cap	152K
PE Ratio	None

ABOUT

Arcadia Biosciences, Inc

Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was incorporated in 2002 and is headquartered in Davis, California.

17DN.F · Arcadia Biosciences, Inc

-

Arcadia Biosciences, Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Arcadia Biosciences, Inc using a moving average strategy